Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Vanderbilt University Medical Center – Thyroid Center
1211 Medical Center DriveNashville, Tennessee, United States
Phone Web
Thyroid diseases can affect your overall health: mood, weight, energy, sleep and concentration. The Vanderbilt Thyroid Center offers comprehensive treatment for thyroid conditions including thyroid cancer, thyroid nodules, abnormal thyroid levels during pregnancy, autoimmune thyroid disease, Graves’ disease, Hashimoto’s disease, hyperthyroidism, hypothyroidism, multiple endocrine neoplasia type 2 ((MEN2), simple goiter (enlarged thyroid), thyroid hormone disorders etc.
We provide thyroid biopsies, testing, surgical and non-surgical procedures, and medical management for thyroid disorders. Since thyroid disorders can involve different areas of the body, our thyroid specialists work together to evaluate your symptoms and provide treatment options that improve your well-being. Our team of experts are specially trained to diagnose and treat thyroid disorders and advanced thyroid cancer.
U.S. News & World Report ranks Vanderbilt University Medical Center as a High Performing Hospital for diabetes and endocrinology, recognizing our advanced treatments and exceptional patient outcomes. Our specialists from endocrinology, oncology, surgery, radiology and pathology meet biweekly in meetings called tumor boards. We review cases together and create a personalized treatment plan for each patient.
Related Content
-
Sajeev S. Kathuria, MDDr. Sajeev Kathuria is a board-certified...
-
Graves’ DiseaseThis indispensable volume is designed to...
-
The Characteristics of Osteoporotic Patients in Graves’ Disease Patients Newly Diagnosed After Menopause: A Pr...Overt hyperthyroidism is associated with...
-
Cost-Utility Analysis Comparing Radioactive Iodine, Anti-Thyroid Drugs and Total Thyroidectomy for Primary Treatment...Objective: Little data is in existence ...
-
Keck Medicine of University of Southern CaliforniaAt Keck Medicine of University of Southe...
-
Horizon Therapeutics plc Reports Strong Third-Quarter 2019 ResultsHorizon Therapeutics plc today announced...
-
FDA Approves First Treatment for Thyroid Eye Disease (Teprotumumab)The U.S. Food and Drug Administration (F...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.